NOCIL [NOCIL] vs Neogen Chemicals [NEOGEN] Detailed Stock Comparison

NOCIL Ltd.

NSE
Loading...

Neogen Chemicals Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: NOCIL Ltd. wins in 13 metrics, Neogen Chemicals Ltd. wins in 7 metrics, with 0 ties. NOCIL Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric NOCIL Ltd. Neogen Chemicals Ltd. Better
P/E Ratio (TTM) 49.71 222.22 NOCIL Ltd.
Price-to-Book Ratio 1.66 5.46 NOCIL Ltd.
Debt-to-Equity Ratio 0.53 141.47 NOCIL Ltd.
PEG Ratio -0.64 -3.52 NOCIL Ltd.
EV/EBITDA 25.02 42.55 NOCIL Ltd.
Profit Margin (TTM) 4.53% 2.41% NOCIL Ltd.
Operating Margin (TTM) 4.10% 11.39% Neogen Chemicals Ltd.
EBITDA Margin (TTM) 4.10% 11.39% Neogen Chemicals Ltd.
Return on Equity 5.84% 4.41% NOCIL Ltd.
Return on Assets (TTM) 5.00% 1.99% NOCIL Ltd.
Free Cash Flow (TTM) $-975.60M $-1.22B NOCIL Ltd.
Dividend Yield 1.08% 0.19% NOCIL Ltd.
1-Year Return -18.89% 22.53% Neogen Chemicals Ltd.
Price-to-Sales Ratio (TTM) 2.26 5.56 NOCIL Ltd.
Enterprise Value $26.06B $53.55B Neogen Chemicals Ltd.
EV/Revenue Ratio 1.99 6.55 NOCIL Ltd.
Gross Profit Margin (TTM) 41.77% 47.11% Neogen Chemicals Ltd.
Revenue per Share (TTM) $79 $310 Neogen Chemicals Ltd.
Earnings per Share (Diluted) $3.57 $7.47 Neogen Chemicals Ltd.
Beta (Stock Volatility) -0.10 0.22 NOCIL Ltd.

NOCIL Ltd. vs Neogen Chemicals Ltd. Stock Performance Analysis

Loading Price Chart...

NOCIL
NEOGEN

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
NOCIL Ltd.1.23%4.88%-0.58%19.85%4.64%7.07%
Neogen Chemicals Ltd.1.51%8.10%24.00%48.67%91.41%75.54%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
NOCIL Ltd.-18.89%-26.65%-23.45%208.89%847.51%695.81%
Neogen Chemicals Ltd.22.53%26.54%147.06%676.07%676.07%676.07%

Performance & Financial Health Analysis: NOCIL Ltd. vs Neogen Chemicals Ltd.

MetricNOCILNEOGEN
Market Information
Market Cap i₹30.50B₹44.76B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,114,980170,744
90 Day Avg. Volume i7,595,297127,390
Last Close₹163.53₹2,064.40
52 Week Range₹125.31 - ₹203.91₹966.70 - ₹2,087.30
% from 52W High-19.80%-1.10%
All-Time High₹336.00 (Jul 29, 2024)₹2,420.00 (Dec 09, 2024)
% from All-Time High-51.33%-14.69%
Growth Metrics
Quarterly Revenue Growth-0.01%0.09%
Quarterly Earnings Growth-0.28%-0.63%
Financial Health
Profit Margin (TTM) i0.05%0.02%
Operating Margin (TTM) i0.04%0.11%
Return on Equity (TTM) i0.06%0.04%
Debt to Equity (MRQ) i0.53141.47
Cash & Liquidity
Book Value per Share (MRQ)₹106.68₹303.78
Cash per Share (MRQ)₹17.90₹57.58
Operating Cash Flow (TTM) i₹165.80M₹645.50M
Levered Free Cash Flow (TTM) i₹1.03B₹348.30M
Dividends
Last 12-Month Dividend Yield i1.08%0.19%
Last 12-Month Dividend i₹2.00₹3.00

Valuation & Enterprise Metrics Analysis: NOCIL Ltd. vs Neogen Chemicals Ltd.

MetricNOCIL (Apr 24, 2026)NEOGEN (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i49.71222.22
Forward P/E i28.4472.26
PEG Ratio i-0.64-3.52
Price to Sales (TTM) i2.265.56
Price to Book (MRQ) i1.665.46
Market Capitalization
Market Capitalization i₹30.50B₹44.76B
Enterprise Value i₹26.06B₹53.55B
Enterprise Value Metrics
Enterprise to Revenue i1.996.55
Enterprise to EBITDA i25.0242.55
Risk & Other Metrics
Beta i-0.100.22
Book Value per Share (MRQ) i₹106.68₹303.78

Financial Statements Comparison: NOCIL Ltd. vs Neogen Chemicals Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricNOCIL (2025)NEOGEN (2025)
Revenue/Sales i13.72B7.58B
Cost of Goods Sold i8.35B4.44B
COGS % of Revenue i60.8%58.6%
Gross Profit i5.37B3.13B
Gross Margin i39.2%41.4%
Research & Development iN/A11.50M
Operating Income (EBIT) i852.40M1.09B
Operating Margin i6.2%14.4%
EBITDA i1.61B1.31B
EBITDA Margin i11.7%17.3%
Pre-Tax Income i1.14B501.60M
Pre-Tax Income % of Revenue i8.3%6.6%
Income Tax i112.80M153.30M
Income Tax % of Revenue i0.8%2.0%
Net Income (Profit) i1.03B348.30M
Profit Margin i7.5%4.6%

Balance Sheet & Liquidity Metrics

MetricNOCIL (2025)NEOGEN (2025)
Cash & Equivalents i299.40M49.60M
Total Current Assets i9.34B10.00B
Total Current Assets % of Revenue i68.1%132.0%
Total Current Liabilities i1.60B7.33B
Total Current Liabilities % of Revenue i11.7%96.8%
Long-Term Debt i71.30M1.94B
Long-Term Debt % of Revenue i0.5%25.6%
Total Shareholders Equity i17.62B7.89B
Retained Earnings i14.52B2.28B
Retained Earnings % of Revenue i105.8%30.1%
Property, Plant & Equipment i8.51B890.30M

Cash Flow Statement Comparison

MetricNOCIL (2025)NEOGEN (2025)
Operating Cash Flow i165.80M645.50M
Operating Cash Flow % of Revenue i1.2%8.5%
Capital Expenditures i-1.20B-3.17B
Free Cash Flow i-975.60M-1.22B
FCF Margin i-7.1%-16.1%
Debt Repayment i-40.50M-718.00M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricNOCILNEOGEN
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i167.02M27.38M
Float Shares i90.99M13.28M
% Held by Insiders i42.10%53.98%
% Held by Institutions i8.45%23.81%
% Held by Public i49.45%22.21%

Dividend Analysis & Yield Comparison: NOCIL Ltd. vs Neogen Chemicals Ltd.

MetricNOCILNEOGEN
Last 12-Month Dividend i₹2.00₹3.00
Last 12-Month Dividend Yield i1.08%0.19%
3-Year Avg Annual Dividend i₹2.67₹2.00
3-Year Avg Dividend Yield i1.14%0.11%
3-Year Total Dividends i₹8.00₹6.00
Ex-Dividend DateJul 30, 2025Sep 19, 2025